EW (Edwards Lifesciences) Interest Expense: $-20 Mil (TTM As of Mar. 2026)

What is Edwards Lifesciences Interest Expense?

Edwards Lifesciences EW +1.18% 97 Interest Expense is $-20 Mil as of Mar. 2026. GuruFocus rates EW with a GF Score™ of 97/100 and a GF Value™ of $93.19 (Fairly Valued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Edwards Lifesciences's interest expense for the three months ended in Mar. 2026 was $ 0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-20 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Edwards Lifesciences's Operating Income for the three months ended in Mar. 2026 was $ 515 Mil. Edwards Lifesciences's Interest Expense for the three months ended in Mar. 2026 was $ 0 Mil. GuruFocus does not calculate Edwards Lifesciences's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Edwards Lifesciences (NYSE:EW) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Edwards Lifesciences's Interest Expense for the three months ended in Mar. 2026 was $0 Mil. Its Operating Income for the three months ended in Mar. 2026 was $515 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $679 Mil.

Edwards Lifesciences's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

GuruFocus does not calculate Edwards Lifesciences's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Edwards Lifesciences Corp has enough cash to cover all of its debt. Its financial situation is stable.

Edwards Lifesciences Interest Expense Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's Interest Expense can be seen below:

Edwards Lifesciences Interest Expense Chart

Edwards Lifesciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-18.40

-19.20

-17.60

-19.80

-20.40

Edwards Lifesciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															0.00	0.00	0.00	-20.40	0.00

97GF Score

Edwards Lifesciences Corp EW

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Edwards Lifesciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-20 Mil mean?

Edwards Lifesciences (EW) has a Interest Expense of $-20 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Edwards Lifesciences and its competitors.

Is Edwards Lifesciences' Interest Expense too high?

Edwards Lifesciences' current Interest Expense is $-20 Mil. Overall, Edwards Lifesciences has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Edwards Lifesciences' Interest Expense compare to BSX and GEHC?

Edwards Lifesciences' Interest Expense of $-20 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Edwards Lifesciences and its competitors. Edwards Lifesciences's current Interest Expense is $-20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Edwards Lifesciences stock overvalued right now?

Based on GuruFocus' analysis, Edwards Lifesciences (EW) is currently considered Fairly Valued. The stock's GF Value™ is $93.19, compared to a current price of $90.78 — trading 2.6% below its estimated fair value. The current Interest Expense is $-20 Mil. Edwards Lifesciences' overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Edwards Lifesciences (EW), the current Interest Expense is $-20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (EW) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of $90.78 is trading 2.6% below its estimated GF Value™ of $93.19. GuruFocus considers Edwards Lifesciences to be Fairly Valued.

Key valuation signals for EW:

Interest Expense: $-20 Mil
GF Value™: $93.19 vs. price of $90.78 (2.6% below fair value)
GF Score™: 97/100 with 5 warning signs

No single metric tells the full story. See the EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Edwards Lifesciences Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies BSX GEHC DXCM STE ZBH PEN GMED PODD BRKR GKOS ABT SYK MDT XTER:SHL XAMS:PHIA SZSE:300760 XSWX:SOON LSE:SN.SHSE:688271 TSE:7733

Other Exchanges EW:Mexico 1EW:Italy EWL:Germany E1WL34:Brazil EWLS:Austria

Address One Edwards Way, Irvine, CA, USA, 92614

Website https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

97GF Score

Get the complete analysis for EW

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.78

Price

$93.19

GF Value

View EW Analysis

See Interest Expense data for all stocks →